InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,444.00
(
2.16%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
-1.03%
)
Bitcoin
62,760.11
(
6.16%
)
Post# of 30046
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

dcspka

Send PM Follow Ignore
Followers 20
Posts 2062
Boards Moderated 0
Alias Born 06/02/2012

dcspka

Re: guardiangel post# 28518

Thursday, 03/26/2015 1:32:36 PM

Thursday, March 26, 2015 1:32:36 PM

Post# of 30046
IMO, the Radient merger will be creative and multi-faceted.

Initially it primarily involves Provista/GCDx. However, from the get-go they will be cutting major partnerships to alleviate the test expansion/ad program costs. Lympro will be in the mix as a spin-off, so will CIT. Enter SRL, UBI, Uni-Pharma, etc.
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up